cultivate(MD) Capital Funds Announces Lead Participation in Portfolio Company Embody’s $10.4 million Series C Funding Round
Funds to Support Commercial Expansion and Post-Market Clinical Studies of Tapestry® for tendon and ligament injuries.
Press Release
culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing
Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Bingham Farms, MI based SpinTech MRI announced a $6.5 million Series A financing.
culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System
Grand Rapids, MI, June 06, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for theirTAPESTRY® RC System for Rotator Cuff Repair.
Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform
FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplement to complete the
Shoulder Innovations Announces FDA Clearance of New InSet™ Stemless Humeral Implant
GRAND RAPIDS, Mich., March 14, 2022—Shoulder Innovations Inc., (SI), a leading innovator in the development of shoulder replacement systems, announces the FDA Clearance of their latest component of the InSetTM Total Shoulder System, the InSetTM Stemless Humeral System. The InSetTM Stemless implant is the latest addition to the innovative and integrated InSetTM system, which already includes the successful InSet™ Glenoid, Humeral Short Stem and
Shoulder Innovations Announces FDA Clearance of New InSet™ Stemless Humeral Implant Read More »
Magnesium Development Company Announces FDA Breakthrough Device Designation for Resorbable HC Screw
Grand Rapids, Mich., January 24, 2022– Magnesium Development Company (MDC), a company with an innovative magnesium (Mg) alloy technology set out to solve what seemed to be an unsolvable problem: the need for a material for use in multiple orthopedic applications that provides appropriate strength for a given indication while not interfering with imaging or requiring